Multilineage gene expression precedes commitment in the hemopoietic system

Genes and Development

Volumn 11, Issue 6, 1997, Pages 774-785

  Hu, Ming ^a   Krause, Diane ^b   Greaves, Mel ^a   Sharkis, Saul ^c   Dexter, Michael ^d   Heyworth, Clare ^d   Enver, Tariq ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

cytokine receptors; Hemopoietic stem cells; lineage specification

Indexed keywords

BETA GLOBIN; CD34 ANTIGEN; CYTOKINE RECEPTOR; GROWTH FACTOR; MYELOPEROXIDASE;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINE; ERYTHROID CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA;

EID: 0030954167     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.6.774     Document Type: Article

References (41)

1. Berardi, A.C., A. Wang, J.D. Levine, P. Lopez, and D.T. Scadden. 1995. Functional isolation and characterisation of human hematopoietic stem cells. Science 267: 104-108.
2. Berthou, C., J.P. Marolleau, C. Lafaurie, A. Soulie, L. Dal-Cortivo, J.F. Bourge, M. Benbinana, and M. Sasportes. 1995. Granzyme B and perform lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilised by chemotherapy and granulocyte colony stimulating factor. Blood 86: 3500-3506.
3. Brady, G., F. Billia, J. Knox, T. Hoang, I.R. Kirsch, E. Voura, R.G. Hawley, R. Cumming, M. Buchwald, K. Siminovitch, N. Miyamoto, G. Boehmelt, and N. Iscove. 1995. Analysis of gene expression in a complex differentiation hierarchy by global amplification of cDNA from single cells. Curr. Biol. 5: 909-922.
4. Brown, J., M.F. Greaves, and H.V. Molgaard. 1991. The gene for the stem cell antigen, CD34, is conserved in mouse and expressed in haemopoietic progenitor cell lines, brain and embryonic fibroblasts. Int. Immunol. 3: 175-184.
5. Caplan, A.I. and C.P. Ordahl. 1978. Irreversible gene repression model for control of development. Science 201: 120-130.
6. Chelly, J., T.P. Concordet, J.C. Kaplan, and A. Kahn. 1989. Illegitimate transcription: Transcription of any gene in any cell type. Proc. Natl. Acad. Sci. 86: 2617-2621.
7. Chirgwin, J.M., A.E. Przybyla, R.J. Macdonald, and W.J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299.
8. Cross, M.A. and T.M. Dexter. 1991. Growth factors in development, transformation, and tumorigenesis. Cell 64: 271-280.
9. Cross, M.A., C.M. Heyworth, A.M. Murrell, E.O. Bockamp, T.M. Dexter, and A.R. Green. 1994. Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line. Oncogene 9: 3013-3016.
10. Crotta, S., S. Nicolis, A. Ronchi, S. Ottolenghi, L. Ruzzi, Y. Shimada, A.R. Migliaccio, and G. Migliaccio. 1990. Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res. 18: 6863-6869.
11. Felsenfeld, G. 1992. Chromatin as an essential part of the transcriptional mechanism. Nature 355: 219-224.
12. Ford, A.M., C.A. Bennett, L.E. Healy, E. Navarro, E. Spooncer, and M.F. Greaves. 1992a. Immunoglobulin heavy-chain and CD3 5-chain gene enhancers are DNase I-hypersensitive in hemopoietic progenitor cells. Proc. Natl. Acad. Sci. 89: 3424-3428.
13. Ford, A.M., L.E. Healy, C.A. Bennett, E. Navarro, E. Spooncer, and M.F. Greaves. 1992b. Multilineage phenotypes of interleukin-3-dependent progenitor cells. Blood 79: 1962-1971.
14. Ford, A.M., C.A. Bennett, L.E. Healy, M. Towatari, M.F. Greaves, and T. Enver. 1996. Regulation of the myeloperoxidase enhancer binding proteins PU1, CEBPα, β, and δ during granulocyte-lineage specification. Proc. Natl. Acad. Sci. 93: 10838-10843.
15. Greaves, M.F., L.C. Chan, A.J. Furley, S.M. Watt, and H.V. Molgaard. 1986. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 67: 1-11.
16. Greaves, M.F., I. Titley, S.M. Colman, H.-J. Buhring, L. Campos, G.L. Castoldi, P. Garrido, G. Gaudeneck, J.-P. Girard, J. Ingles-Esteve, R. Invernizzi, W. Knapp, P.M. Lansdorp, F. Lanza, H. Merle-Beral, C. Parravicini, K. Razak, F. Ruiz-Cabello, T.A. Springer, C.E. Van Der Schoot, and D.R. Sutherland. 1995. CD34 cluster workshop report. In Leukocyte typing V (ed. S. Schlossmanl), pp. 840-846. Oxford University Press, Oxford, UK.
17. Greenberger, J.S., M.A. Sakakeeny, R.K. Humphries, C.J. Eaves, and R.J. Eckner. 1983. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc. Natl. Acad. Sci. 80: 2931-2935.
18. Hampson, I.N., M.A. Cross, C.M. Heyworth, L. Fairbairn, G.E. Cowling, and T.M. Dexter. 1992. Expression and downregulation of cytotoxic cell protease 1 or Granzyme "B" transcripts during myeloid differentiation of interleukin-3-de-pendent murine stem cell lines. Blood 80: 3097-3105.
19. Hampson, I.N., L. Hampson, N. Pinkoski, M. Cross, C.M. Heyworth, R.C. Bleackley, E. Atkinson, and T.M. Dexter. 1997. Identification of a serpin specifically expressed in multipotent and bipotent hematopoietic progenitor cells and in activated T-cells. Blood 89: 108-118.
20. Heberlein, C., K.D. Fischer, M. Stoffel, J. Nowock, A. Ford, U. Tessmer, and C. Stocking. 1992. The gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: Evidence for differentiation stage-specific regulation. Mol. Cell. Biol. 12: 1815-1826.
21. Heyworth, CM., T.M. Dexter, O. Kan, and A.D. Whetton. 1990. The role of haemopoietic growth factors in self-renewal and differentiation of IL-3-dependent multipotential stem cells. Growth Factors 2: 197-211.
22. Heyworth, C.M., J. Hampson, T.M. Dexter, F. Walker, A.W. Burgess, O. Kan, N. Cook, S. Valance, and A.D. Whetton. 1991. Development of multipotential haemopoietic stem cells to neutrophils is associated with increased expression of receptors for granulocyte-macrophage colony stimulating factor: Altered biological responses to GM-CSF during development. Growth Factors 5: 87-98.
23. Heyworth, C.M., M. Alaudin, M. Cross, L.J. Fairbairn, T.M. Dexter, and A.D. Whetton. 1995. Erythroid development of the FDCP-mix A4 multipotent cell line is governed by the relative concentrations of erythropoietin and interleukin 3. Br. J. Haem. 91: 15-22.
24. Jimenez, G., S.D. Griffiths, A.M. Ford, M.F. Greaves, and T. Enver. 1992. Activation of the β-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. 89: 10618-10622.
25. Krause, D.S., T. Ito, M.J. Fackler, O.M. Smith, M.I. Collector, S.J. Sharkis, and W.S. May. 1994. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84: 691-701.
26. Lajtha, L.G. 1979. Stem cell concepts. Differentiation 14:23-34.
27. McKinstry, W.J., C.-L. Li, J.E.J. Rasko, N. Nicola, G. Johnson, and D. Metcalf. 1997. Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood 89: 65-71.
28. Metcalf, D. 1989. The molecular control of cell division, differentiation, commitment and maturation in haemopoietic cells. Nature 339: 27-30.
29. Miyajima, A., A.L. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82: 1960-1974.
30. 125I-multipotential colony-stimulating factor (interleukin-3) by FDCP-1 cells. Growth Factors 1: 29-39.
31. Orlic, D., S. Anderson, I.G. Biesecker, B.P. Sorrentino, and D.M. Bodine. 1995. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Proc. Natl. Acad. Sci. 92: 4601-4605.
32. Palacios, R., H. Karasuyama, and A. Rolink. 1987. Ly1+ PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J. 6: 3687-3693.
33. Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58-62.
34. Spooncer, E., D. Boettiger, and T.M. Dexter. 1984. Continuous in vitro generation of multipotential stem cell clones from src-infected cultures. Nature 310: 228-230.
35. Spooncer, E., C.M. Heyworth, A. Dunn, and T.M. Dexter. 1986. Self-renewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation 31: 111-118.
36. Suda, J., T. Suda, and M. Ogawa. 1984. Analysis of differentiation of mouse hemopoietic stem cells in culture by sequential replating of paired progenitors. Blood 64: 393-399.
37. Tsai, F.Y., G. Keller, F.C. Kuo, M. Weiss, J. Chen, M. Rosenblatt, F.W. Alt, and S.H. Orkin. 1994. An early haemopoietic defect in mice lacking the transcription factor GATA-2. Nature 371: 221-226.
38. Tsai, S.F., D.I. Martin, L.I. Zon, A.D. D'Andrea, G.G. Wong, and S.H. Orkin. 1989. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339: 446-451.
39. Warner, N.L., M.A.S. Moore, and D. Metcalf. 1969. A transplantable myelomonocytic leukaemia in BALB/c mice: Cytology, karyotype muramidase content. J. Nat. Cancer Inst. 43: 1108-1112.
40. Wijgerde, M., F. Grosveld, and P. Fraser. 1995. Transcription complex stability and chromatin dynamics in vivo. Nature 377: 209-213.
41. Zhu, J., C.A. Bennett, A.D. MacGregor, M.F. Greaves, G.H. Goodwin, and A.M Ford. 1994. A myeloid-lineage-specific enhancer upstream of the mouse myeloperoxidase (MPO) gene. Leukemia 8: 717-723.